BD, also known as Becton, Dickinson and Co., on Tuesday said it appointed Simon Campion as executive vice president and president of its Medical segment, effective July 1.
Campion, 51, will replace Alberto Mas, who previously announced his intent to retire from BD.
In this role, Campion will be responsible for the global strategic, operational and commercial performance of the Medical segment portfolio of the Franklin Lakes-based company and will be accountable for delivering the segment’s innovation agenda aligned to the BD 2025 strategy.
Campion will also continue to lead the Interventional segment in the interim, until a successor is named. He will report to Tom Polen, chairman, CEO and president of BD.
“Simon is a proven business leader with excellent strategic and operational skills and deep global experience,” Polen said. “Since joining BD from the Bard acquisition, Simon has been integral in the integration and growth of the legacy Bard businesses across the Interventional segment and is well positioned to lead BD’s largest segment.”
BD completed its acquisition of C.R. Bard Inc. in December 2017, creating a new health care industry leader with approximately $16 billion in annualized revenue.
Campion has served as EVP and president of the Interventional segment for BD since September 2018. Prior to that, he was president of the BD Surgery business unit, where he integrated legacy Bard and BD product platforms into an integrated Surgery offering.
Campion joined Bard in 2008 and held leadership roles in numerous Bard businesses in the U.S. and Europe. Prior to Bard, he held marketing and research & development roles at Cook Medical and Boston Scientific.
